scholarly journals Surgery for Tricuspid Valve Endocarditis in the Current Era

2021 ◽  
Author(s):  
Sameh M. Said
Keyword(s):  
Tricuspid Valve ◽  
Medical Management ◽  
Recurrent Infection ◽  
Drug Induced ◽  
First Line Therapy ◽  
Cardiac Devices ◽  
Hemodynamic Deterioration ◽  
Implantable Cardiac Devices ◽  
Pulmonary Embolization ◽  
Tricuspid Valve Endocarditis

Tricuspid valve endocarditis (TVE) continues to be on the rise and has been mostly attributed to the growing epidemic of intravenous drug abuse (IVDA). Other risk factors include long-term indwelling central venous catheters and implantable cardiac devices. While medical management continues to be the first line therapy, surgery is indicated when medical management fails, and in the presence of hemodynamic deterioration, recurrent septic pulmonary embolization and/or persistent sepsis. Tricuspid valve (TV) excision once was the main surgical strategy, but other options include TV repair/reconstruction and replacement. Remaining challenges include management of drug-induced endocarditis and the best strategy for recurrent infection.

scholarly journals Isolated Native Tricuspid Valve Endocarditis in a Nonintravenous Drug User

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Habtewold Shibru ◽  
Ermias shenkutie Greffie ◽  
Zenahbezu Abay ◽  
Oumer Abdu Muhie
Keyword(s):  
Infective Endocarditis ◽  
Tricuspid Valve ◽  
Drug Users ◽  
High Morbidity ◽  
Central Venous ◽  
Cardiac Device ◽  
Rural Ethiopia ◽  
Cardiac Devices ◽  
Underlying Risk ◽  
Tricuspid Valve Endocarditis

Infective endocarditis (IE) is a disease characterized by high morbidity and mortality. IE was first described in the mid-16th century. Right-sided infective endocarditis (RSIE) represents 5% to 10% of all IE episodes in adults. RSIE can be divided into three groups according to the underlying risk factors: intravenous drug users (IDUs), cardiac device carriers, and the “three noes” group (no left-sided IE, no IDUs, and no cardiac devices). Tricuspid valve endocarditis in nonintravenous drug users can occur in a variety of conditions including congenital heart disease, intracardiac devices, central venous catheters, and immunologically debilitated patients. Due to the rareness of isolated native nonrheumatic tricuspid valve endocarditis, here, we like to present an 18-year-old male from rural Ethiopia with the diagnosis of isolated native tricuspid valve endocarditis that was treated and cured.

Predictors of Surgical Outcome in Isolated Tricuspid Valve Endocarditis: Single Center Experience of 60 Patients

2017 ◽  
Vol 65 (08) ◽  
pp. 634-638 ◽  
Author(s):  
Mahmoud Singer ◽  
Tarek Mohsen ◽  
Amr Roushdy ◽  
Alsayed Akl ◽  
Marwa Mashaal ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Pericardial Effusion ◽  
Hospital Mortality ◽  
Tricuspid Valve ◽  
Surgical Outcome ◽  
Significant Risk ◽  
Pulmonary Embolization ◽  
Preoperative Predictors ◽  
Tricuspid Valve Endocarditis

Background Tricuspid valve (TV) endocarditis may be associated with serious complications, and 25% of patients require surgical intervention. However, indications and outcomes of surgery are not clearly identified. In this study, 60 patients are retrospectively reviewed to determine preoperative predictors of surgical outcome. Patients and Methods Sixty patients with isolated TV endocarditis who underwent surgery in the period between January 2012 and December 2016 are reviewed retrospectively from the medical records of Cairo University Hospitals. Forty-two (70%) patients were males, and 18 (30%) were females with a mean age of 29.3 ± 10.6 years. Eleven patients had an underlying cardiac lesion, and 27 patients were intravenous (IV)-drug addicts. Results TV repair could be done in nine (15%) patients, and the rest received TV replacement with biological valves. Twenty-four (40%) patients experienced postoperative complications. On multivariate analysis, a vegetation size >2.2 cm was a significant preoperative predictor for embolic complications and prolonged ventilation. In-hospital mortality occurred in 10 (16.67%) patients. Significant preoperative predictors of mortality were pulmonary embolization, congestive heart failure (HF), and the presence of pericardial effusion. During a mean follow-up period of 25 ± 12.6 months with echocardiography, two (4%) IV drug user patients developed recurrence of infection and needed reoperation. Conclusion Surgery for tricuspid valve endocarditis (TVE) can be performed with good early and mid-term results. A large size of vegetations >2.2 cm is a significant risk factor for embolic complications. Preoperative predictors of in-hospital mortality according to our study are pulmonary embolization, congestive heart failure, and pericardial effusion.

Drug-Induced Movement Disorders

2015 ◽  
Vol 25 (2) ◽  
pp. 70-77
Author(s):  
Amy Lustig ◽  
Cesar Ruiz
Keyword(s):  
Movement Disorders ◽  
Medical Management ◽  
Disease Process ◽  
Underlying Disease ◽  
Extrapyramidal Symptoms ◽  
Drug Induced ◽  
General Overview ◽  
Management Approaches ◽  
Broad Understanding ◽  
Underlying Disease Process

The purpose of this article is to present a general overview of the features of drug-induced movement disorders (DIMDs) comprised by Parkinsonism and extrapyramidal symptoms. Speech-language pathologists (SLPs) who work with patients presenting with these issues must have a broad understanding of the underlying disease process. This article will provide a brief introduction to the neuropathophysiology of DIMDs, a discussion of the associated symptomatology, the pharmacology implicated in causing DIMDs, and the medical management approaches currently in use.

Tricuspid valve surgery in patients with isolated tricuspid valve endocarditis - Analyzation of perioperative parameters and long-term outcomes

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
B. Pfannmüller ◽  
M. Kahmann ◽  
C. Binner ◽  
P. Davierwala ◽  
M. Misfeld ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Valve Surgery ◽  
Long Term Outcomes ◽  
Tricuspid Valve Surgery ◽  
Tricuspid Valve Endocarditis

Automatic Remote Monitoring of Implantable Cardiac Devices in Clinical Practice – The Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) Trial

2010 ◽  
Vol 6 (3) ◽  
pp. 87
Author(s):  
Niraj Varma ◽  
Keyword(s):  
Clinical Practice ◽  
Remote Monitoring ◽  
Home Monitoring ◽  
Implantable Devices ◽  
Cardiac Device ◽  
Cardiac Devices ◽  
Enhance Patient Safety ◽  
Implantable Cardiac Devices ◽  
Post Implantation

The use of implantable electronic cardiac devices is increasing. Post-implantation follow-up is important for monitoring both device function and patient condition; however, clinical practice is inconsistent. For example, implantable cardioverter–defibrillator follow-up schedules vary from every three months to yearly according to facility and physician preference and the availability of resources. Importantly, no surveillance occurs between follow-up visits. By contrast, implantable devices with automatic remote monitoring capability provide a means for performing constant surveillance, with the ability to identify salient problems rapidly. The Lumos-T Reduces Routine Office Device Follow-up Study (TRUST) demonstrated that remote home monitoring reduced clinic burden and allowed early detection of patient and/or system problems, enabling efficient monitoring and an opportunity to enhance patient safety. The results of the trial have significant implications for the management of patients receiving all forms of implantable electronic cardiac device.

Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users

2021 ◽  
Author(s):  
Yasir N. Akhtar ◽  
William A. Walker ◽  
Umar Shakur ◽  
Gary Smith ◽  
Syed S. Husnain ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Tricuspid Valve ◽  
Drug Users ◽  
Intravenous Drug ◽  
Intravenous Drug Users ◽  
Tricuspid Valve Endocarditis

SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES

2013 ◽  
Vol 41 ◽  
pp. S3 ◽  
Author(s):  
E. Athan ◽  
V.H. Chu ◽  
P. Tattevin ◽  
C. Selton-Suty ◽  
P. Jones ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Clinical Characteristics ◽  
Cardiac Devices ◽  
Implantable Cardiac Devices

scholarly journals Tricuspid valve endocarditis

2017 ◽  
Vol 6 (3) ◽  
pp. 255-261 ◽  
Author(s):  
Syed T. Hussain ◽  
James Witten ◽  
Nabin K. Shrestha ◽  
Eugene H. Blackstone ◽  
Gösta B. Pettersson
Keyword(s):  
Tricuspid Valve ◽  
Tricuspid Valve Endocarditis

scholarly journals Tricuspid valve endocarditis in pregnancy: a case report and review of the literature

2021 ◽  
Vol 11 (1) ◽  
pp. 99-102
Author(s):  
Robert Libera ◽  
Kyle Macaulay ◽  
Anthony A. Donato ◽  
Jared Green ◽  
Christine McCarty
Keyword(s):  
Case Report ◽  
Tricuspid Valve ◽  
Review Of The Literature ◽  
Tricuspid Valve Endocarditis ◽  
In Pregnancy

A CASE REPORT ON CUTIBACTERIUM ACNES- FROM COMMENSAL TO PATHOGEN

2021 ◽  
pp. 66-67
Author(s):  
R. Prabha ◽  
S. Pramodhini ◽  
Joshy M Esaow
Keyword(s):  
Case Report ◽  
Blood Culture ◽  
Virulence Factors ◽  
Propionibacterium Acnes ◽  
Gram Positive ◽  
Cardiac Devices ◽  
Alternate Explanation ◽  
Cutibacterium Acnes ◽  
Implantable Cardiac Devices ◽  
Slow Growing

Propionibacterium acnes (Cutibacterium acnes) is an anaerobic, gram-positive, slow growing bacteria. It can produce various virulence factors like bioactive exocellular products and metabolites. P.acnes blood isolates were considered signicant if two or more separate blood culture sets were positive on the same day and if systemic inammatory response syndrome (SIRS) was present without any alternate explanation. C.acnes if found in the blood of patients with implantable cardiac devices it should be considered as more than just a skin contaminant. These patients should be treated with appropriate therapies to prevent annihilatory consequences.

Sign in / Sign up

Export Citation Format

Share Document